Plasma and urine concentrations of a new adamantane derivative.
D000978:Antiparkinson Agents / Q000097:blood / Q000652:urine; D001952:Bridged-Ring Compounds / Q000032:analysis* / Q000097:blood / Q000652:urine; D003516:Cycloparaffins / Q000097:blood / Q000652:urine; D006207:Half-Life; D006801:Humans; D008297:Male; D011437:Propylamines / Q000097:blood / Q000652:urine
D000978:Antiparkinson Agents; D001952:Bridged-Ring Compounds; D003516:Cycloparaffins; D011437:Propylamines